SureTrader Nadex Advertisement
Home > Boards > US Listed > Biotechs >

Bristol-Myers (BMY)

BMY RSS Feed
Add BMY Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 2/23/2017 3:40:30 PM - Followers: 31 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMY
Current Price
Volume:
Bid Ask Day's Range
SureTrader
BMY News: Bristol-Myers Squibb Prices $1.5 Billion of Senior Notes 02/22/2017 06:00:00 PM
BMY News: Bristol-Myers Squibb Appoints Three New Independent Directors 02/21/2017 06:59:00 AM
BMY News: First Comprehensive Pediatric Hematology-Oncology Initiative Launched in Africa 02/21/2017 03:00:00 AM
BMY News: Bristol-Myers Squibb to Take Part in Leerink 6th Annual Global Health Care Conference 02/08/2017 10:54:00 AM
BMY News: Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) in Previously Treated Locally Advanced or Metastatic Urothe... 02/02/2017 04:15:00 PM
PostSubject
#421  Sticky Note Musings on 4Q16 results /2017 guidance: #msg-128169138. DewDiligence 01/26/17 12:27:05 PM
#453   The interest rates look pretty attractive for BMY (#msg-128922451). DewDiligence 02/23/17 03:40:29 PM
#452   Bristol-Myers Squibb Co (NYSE:BMY) To Sell Senior Notes trendmkr 02/23/17 02:14:08 PM
#451   Bristol-Myers Looms as Pharma's Next Megadeal as Activists Join chmcnfunds 02/23/17 10:36:50 AM
#450   $1.5B bond issue to fund stock buyback (in part): DewDiligence 02/22/17 06:20:34 PM
#449   Schedule 13D is an SEC filing that must chmcnfunds 02/22/17 02:41:38 PM
#448   Maybe hit the $57.21 it spiked to yesterday: chmcnfunds 02/22/17 12:15:56 PM
#447   Nothing new, but context: chmcnfunds 02/22/17 07:24:20 AM
#446   WSJ reports Icahn has taken a stake -- chmcnfunds 02/21/17 03:43:45 PM
#445   JANA influence: chmcnfunds 02/21/17 08:22:26 AM
#444   Strange after-hours trade yesterday: chmcnfunds 02/17/17 08:04:21 AM
#443   Would Pfizer, Roche or Novartis megamerge with BMS? chmcnfunds 02/15/17 02:03:51 PM
#442   Chatter has legs: chmcnfunds 02/15/17 11:49:11 AM
#441   Could Gilead Really Buy Bristol-Myers Squibb? chmcnfunds 02/15/17 09:23:00 AM
#440   BMY, I am Long term, collecting divy's,(2.90%) while Norton1973 02/15/17 07:35:26 AM
#439   BMY, PFE… 05:43 chmcnfunds 02/15/17 07:31:49 AM
#438   I caught Bristol-Myers BMY, close to a 52 Norton1973 02/14/17 03:52:21 PM
#437   From SA: chmcnfunds 02/14/17 12:50:04 PM
#436   Take-over chatter causing a pop: chmcnfunds 02/14/17 12:10:45 PM
#435   Bit surprised since I believe folks generally have chmcnfunds 02/07/17 10:23:07 AM
#434   The Endpoints blog you posted has some misleading DewDiligence 02/07/17 09:42:30 AM
#433   Bristol-Myers partner Innate concedes a PhII flop for chmcnfunds 02/06/17 08:38:27 AM
#432   Bristol-Myers' Lirilumab Flunks Mid-Stage Study In Leukemia chmcnfunds 02/06/17 08:31:15 AM
#431   You’re correct (my bad). Keytruda sales for all DewDiligence 02/02/17 05:46:06 PM
#430   Nivolumab for Treatment of Urothelial Carcinoma chmcnfunds 02/02/17 02:26:11 PM
#429   Not actually if the chart figures are correct, chmcnfunds 02/02/17 12:13:20 PM
#428   As was mentioned on Twitter, Opdivo sales in DewDiligence 02/02/17 12:03:34 PM
#427   https://pbs.twimg.com/media/C3qGlZ4UYAQtU_2.jpg chmcnfunds 02/02/17 11:56:22 AM
#426   Merck Makes Nice With Bristol-Myers Squibb chmcnfunds 01/31/17 10:46:23 AM
#425   Bristol-Myers Squibb (BMY) Q4 2016 Results - Earnings chmcnfunds 01/30/17 10:33:50 AM
#424   WSJ’s Charley Grant agrees: DewDiligence 01/26/17 01:23:35 PM
#423   I've been in BMY for years. What mgt 2014shelby 01/26/17 01:06:37 PM
#422   Sure hope they do. Thought that they might chmcnfunds 01/26/17 12:57:55 PM
#421   Musings on 4Q16 results /2017 guidance: #msg-128169138. DewDiligence 01/26/17 12:27:05 PM
#420   They need to consider increasing dividend and buy 2014shelby 01/26/17 12:11:08 PM
#419   zach [email protected] 2m2 minutes ago chmcnfunds 01/26/17 10:48:53 AM
#418   I am somewhat concerned about it, but (as DewDiligence 01/26/17 09:45:23 AM
#417   Thanks for the info. You have no great chmcnfunds 01/26/17 09:42:27 AM
#416   My concern is their very high Asian exposure DewDiligence 01/26/17 09:38:28 AM
#415   BMY's quarterly GAAP tax rates during 2015 were DewDiligence 01/26/17 09:37:20 AM
#414   A lot of interesting info, obviously, but one chmcnfunds 01/26/17 09:25:47 AM
#413   BMY’s own PR on 4Q16 results: DewDiligence 01/26/17 09:09:05 AM
#412   From seeking Alpha: chmcnfunds 01/26/17 08:47:13 AM
#410   Got to wonder how Trump's trade policies are chmcnfunds 01/24/17 10:13:43 AM
#409   I've seen a couple of speculations lately: chmcnfunds 01/24/17 08:45:29 AM
#408   I wonder whether MRK could somehow fashion a north40000 01/23/17 08:27:33 PM
#407   I don't think BMY needs to shake things DewDiligence 01/23/17 09:45:35 AM
#406   Bristol-Myers: An Activist Shows Up, Finally chmcnfunds 01/23/17 09:10:15 AM
#405   Gapped up from $50.42 back in OCT of T695 01/20/17 04:39:20 PM
#404   Seems like easy money given they still have chmcnfunds 01/20/17 04:37:46 PM
#403   Nice chunk of change even for a company DewDiligence 01/20/17 04:36:29 PM
PostSubject